Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending October 2012. The report serves as a notification of transactions involving directors, persons discharging managerial responsibility, or connected persons, specifically regarding changes in share interests.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a regulatory disclosure of a specific share transaction rather than a financial performance report.
Material Changes
The filing details a specific acquisition of 10 Ordinary Shares by Mrs. K Thomson, a connected person to Director Mr. P C Thomson. The shares were acquired on October 4, 2012, at a price of 1460.066 pence per share. This transaction resulted from the reinvestment of dividends paid on shares held in the GlaxoSmithKline ShareReward Plan.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the disclosure of the share transaction in accordance with Disclosure and Transparency Rule 3.1.4R(1)(c).
Key Facts for Investor Verification
- Transaction Date: October 4, 2012.
- Connected Person: Mrs. K Thomson (connected to Director Mr. P C Thomson).
- Transaction Type: Acquisition of 10 Ordinary Shares via dividend reinvestment.
- Share Price: 1460.066 pence per Ordinary Share.
- Notification Date: October 5, 2012.